Caveat from the discussion: > It is unclear what the prevalence of antibody is in individuals with subclinical or asymptomatic infections and how this assay pe

Caveat from the discussion: > It is unclear what the prevalence of antibody is in individuals with subclinical or asymptomatic infections and how this assay performs in an asymptomatic population.